HemoShear

Top GSK/ViiV scientist who co-invented an HIV blockbuster books a trip to biotech
Endpoints
Wed, 09/25/19 - 09:16 am
GSK
ViiV
Tivicay
HIV
HemoShear
Takeda is beefing up its NASH pipeline with a $470M discovery deal with HemoShear
Endpoints
Tue, 10/17/17 - 10:13 am
Takeda
NASH
drug discovery
HemoShear
R&D